These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 204604)

  • 41. Detection of virus and cellular-determined antigens in situ using [125I]protein A and autoradiography.
    Moar MH; Rosén A; Klein G
    J Immunol Methods; 1979; 30(3):219-29. PubMed ID: 227963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antigens and DNA of a chimpanzee agent related to Epstein-Barr virus.
    Gerber P; Pritchett RF; Kieff ED
    J Virol; 1976 Sep; 19(3):1090-9. PubMed ID: 184297
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of Epstein-Barr virus early antigen-D and its antibodies by passive hemagglutination.
    Ogburn CA; Zajac BA
    Int J Cancer; 1977 Feb; 19(2):150-60. PubMed ID: 190173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle in a new set of somatic cell hybrids.
    Klein G; Clements G; Zeuthen J; Westman A
    Cancer Lett; 1977 Jul; 3(1-2):91-8. PubMed ID: 196751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two distinct antigenic components in an Epstein-Barr virus-related early product induced by halogenated pyrimidines in non-producing human lymphoblastoid cells.
    Sugawara K; Osato T
    Nat New Biol; 1973 Jun; 243(128):209-10. PubMed ID: 4351756
    [No Abstract]   [Full Text] [Related]  

  • 46. Enzyme-linked immunosorbent assay for antibodies to Epstein-Barr virus-associated early antigens and the viral capsid antigen.
    Dölken G; Boldt C; Lange W; Weitzmann U; Löhr GW; Rosén A
    Cancer Detect Prev; 1983; 6(1-2):287-92. PubMed ID: 6309387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of Epstein-Barr virus (EBV) antigens II. Detection of early antigen (S) using anticomplement immunofluorescence (ACIF) et complement fixation (CF) tests.
    Lenoir G; Berthelon MC; Favre MC; De-Thé G
    Biomedicine; 1975 Dec; 23(10):461-4. PubMed ID: 177116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between Epstein-Barr virus-associated nuclear antigen and cell viability in human cell lines.
    Suzuki M; Hinuma Y
    Gan; 1975 Feb; 66(1):103-5. PubMed ID: 168112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epstein-Barr virus: detection of genome in somatic cell hybrids of Burkitt lymphoblastoid cells.
    Glaser R; Nonoyama M
    Science; 1973 Feb; 179(4072):492-3. PubMed ID: 4350214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rescue of Epstein-Barr virus from somatic cell hybrids of Burkitt lymphoblastoid cells.
    Glaser R; Rapp F
    J Virol; 1972 Aug; 10(2):288-96. PubMed ID: 4342246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of recombinant Epstein-Barr virus early antigen for detection of antibody in patients with nasopharyngeal carcinoma.
    Liu MT; Lin LS; Yu Y; Chung TT; Hsu CY; Chen JT; Jeng KC
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):7-15. PubMed ID: 8820030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of dibutyryl cyclic AMP on the induction of Epstein-Barr virus in hybrid cells.
    Zimmerman JE; Glaser R; Rapp F
    J Virol; 1973 Dec; 12(6):1442-5. PubMed ID: 4357515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of two newly established EBV-containing lymphoblastoid cell lines from patients with myeloid leukemias.
    Chang YS; Shih LY; Peng CL; Chen SH; Liu ST
    Leuk Res; 1990; 14(4):309-20. PubMed ID: 2159089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Time of synthesis and cellular location of Epstein-Barr virus-specified polypeptides radioimmunoprecipitated from iododeoxyuridine-induced Burkitt lymphoma/somatic cell hybrids.
    Durnford JM; Scanlon PA; Glaser R
    J Gen Virol; 1982 May; 60(Pt 1):39-48. PubMed ID: 6284867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The action of DNA antagonists on Epstein-Barr virus (EBV)-associated early antigen (EA) in Burkitt lymphoma lines.
    Gergely L; Klein G; Ernberg I
    Int J Cancer; 1971 Mar; 7(2):293-302. PubMed ID: 4932228
    [No Abstract]   [Full Text] [Related]  

  • 57. Blocking of acid-fixed nuclear binding of Epstein-Barr virus nuclear antigen (EBNA) by different DNA species.
    Hirsch I; Kuchlerová L; Brichácek B; Suchánková A; Vonka V
    J Gen Virol; 1979 Sep; 44(3):849-52. PubMed ID: 231093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV.
    Klein G; Sugden B; Leibold W; Menezes J
    Intervirology; 1974; 3(4):232-44. PubMed ID: 4376804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of mitogens on the expression of Epstein-Barr virus antigens in human lymphoid cell lines.
    Tovey MG; Lenoir G; Begon-Lours J; Tapiero H; Rochette-Egly C
    J Immunol; 1979 Jul; 123(1):138-42. PubMed ID: 221589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of two early gene products of Epstein-Barr virus by fluorescence flow cytometry.
    Lidin B; Gartland L; Marshall G; Sanchez V; Lamon EW
    Viral Immunol; 1993; 6(2):97-107. PubMed ID: 8216716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.